Masanori Hizue

Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions: correlation analysis of 142 approved drugs in Japan

Chihiro Tamaki, Takashi Nagayama, Masamichi Hashiba et al. · The Journal of Toxicological Sciences · 2013 · 79 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury

Shingo Oda, Yuka Uchida, Michael D. Aleo et al. · Archives of Toxicology · 2020 · 24 citations

Medicine, Cell Biology, Oncology +17

Discovery of (−)-6-[2-[4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone—A potent NR2B-selective N-methyl d-aspartate (NMDA) antagonist for the treatment of pain

Makoto Kawai, Kazuo Ando, Yukari Matsumoto et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 15 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Involvement of N-methyl-D-aspartate-type glutamate receptor ε1 and ε4 subunits in tonic inflammatory pain and neuropathic pain

Masanori Hizue, CHANG-HONG PANG, Masayuki Yokoyama · Neuroreport · 2005 · 14 citations

Life Sciences, Neurobiology, Neuroscience +16

Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor

Takako Okumura, Yoko Murata, Masanori Hizue et al. · European Journal of Pharmacology · 2006 · 11 citations

Medicine, Medicinal Chemistry, Pharmacology +7